Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gin Hwa BiotechROCO:7806 20 PS Ratio is 2.76 as of Aug. 04, 2026, which is 21% below its 10-year median of 3.49. GuruFocus rates ROCO:7806 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 931 Biotechnology companies, Gin Hwa Biotech ranks better than 77.98% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Gin Hwa Biotech's share price is NT$57.90.
Gin Hwa Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$20.96. Hence, Gin Hwa Biotech's PS Ratio for today is 2.76.
Good Sign:
Gin Hwa Biotech Inc stock PS Ratio (=2.79) is close to 2-year low of 2.79.
The historical rank and industry rank for Gin Hwa Biotech's PS Ratio or its related term are showing as below:
ROCO:7806'
s PS Ratio Range Over the Past 10 Years
Min: 2.76 Med: 3.49 Max: 3.92
Current: 2.76
During the past 4 years, Gin Hwa Biotech's highest PS Ratio was 3.92. The lowest was 2.76. And the median was 3.49.
ROCO:7806's PS Ratio is ranked better than 77.98% of 931
companies
in the Biotechnology industry
Industry Median: 8.91
vs ROCO:7806: 2.76
During the past 12 months, the average Revenue per Share Growth Rate of Gin Hwa Biotech was 12.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 26.70% per year.
During the past 4 years, Gin Hwa Biotech's highest 3-Year average Revenue per Share Growth Rate was 26.70% per year. The lowest was 26.70% per year. And the median was 26.70% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gin Hwa Biotech PS Ratio Related Terms
Gin Hwa Biotech PS Ratio Historical Data
* Premium members only.
The historical data trend for Gin Hwa Biotech's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7806 vs VRTX, REGN, RVMD: PS Ratio Comparison
For the Biotechnology subindustry, Gin Hwa Biotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gin Hwa Biotech PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gin Hwa Biotech's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gin Hwa Biotech's Share Price of today is NT$57.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gin Hwa Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$20.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gin Hwa Biotech (ROCO:7806) has a PS Ratio of 2.76 as of Aug. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gin Hwa Biotech and its competitors. This is 21% below median its historical median of 3.49. Over the past decade, Gin Hwa Biotech's PS Ratio has ranged from 2.76 to 3.92. According to the industry distribution chart, Gin Hwa Biotech ranks #205 out of 931 companies in the Biotechnology industry, placing it in the top 22%.
Is Gin Hwa Biotech's PS Ratio too high?
Gin Hwa Biotech's current PS Ratio of 2.76 is 21% below median its 10-year median of 3.49. Over the past 10 years, this metric has ranged from a low of 2.76 to a high of 3.92. The Biotechnology industry median PS Ratio is 8.91. Gin Hwa Biotech's value of 2.76 is 69% below this industry median. Based on the distribution chart, Gin Hwa Biotech ranks #205 out of 931 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gin Hwa Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #205 out of 931 companies for PS Ratio. This places Gin Hwa Biotech in the top 22% of its industry — outperforming the majority of peers. The industry median PS Ratio is 8.91. Gin Hwa Biotech's value of 2.76 is 69% below this benchmark. Historically, Gin Hwa Biotech's own PS Ratio has ranged from 2.76 to 3.92 over the past decade. While the company's 10-year median is 3.49 vs. the industry median of 8.91, Gin Hwa Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 8.91, based on 931 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gin Hwa Biotech's current PS Ratio of 2.76 is 69% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gin Hwa Biotech and its competitors. For the Biotechnology industry, the median PS Ratio is 8.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gin Hwa Biotech's current PS Ratio is 2.76, which is 21% below median its own 10-year median of 3.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current PS Ratio of 2.76. The current PS Ratio is 2.76, which is 21% below median its 10-year median of 3.49 and 69% below the Biotechnology industry median of 8.91. Gin Hwa Biotech's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current PS Ratio is 2.76 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
20GF Score
Get the complete analysis for ROCO:7806
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7806 has been successfully added to your 
